Abstract # 2320 Radioimmunotherapy with Yttrium 90 Ibritumomab Tiuxetan (Zevalin

Presenter: Meredith, Ruby

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos


Authors:
Meredith, Ruby (1) ; Schilder, Russell J (2) ; Emmanouilides, Christos (3) ; Vo, Katie (4) ; Witzig, Thomas E (5) ; Flinn, Ian W (6) ; Darif, Mohamed (4) ; Gordon, Leo I (7) ; Molina, Arturo (4) .

Institutions:
1. Department of Radiation Oncology, University of Alabama Medical Center, Birmingham, AL,
USA.
2.
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

3.
Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.

4.
Global Medical Affairs, Biogen Idec, Inc., San Diego, CA, USA.

5.
Division of Hematology, Mayo Clinic, Rochester, MN, USA.

6.
The Sidney Kimmel Comprehensive Cancer, John Hopkins University, Baltimore, MD, USA.

7.
Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.


Click on images to enlarge (a new pop-up window will open)

Title:



E-mail a friend about this abstract:
Enter email address:   





Abstracts main page


Logout